Earnings Summary

BIODESIX INC’s revenue jumped 38.3% since last year same period to $9.06Mn in the Q1 2023. On a quarterly growth basis, BIODESIX INC has generated -5.74% fall in its revenue since last 3-months.

BIODESIX INC’s net profit fell -9.82% since last year same period to $-17.12Mn in the Q1 2023. On a quarterly growth basis, BIODESIX INC has generated 15.84% jump in its net profits since last 3-months.

BIODESIX INC’s net profit margin jumped 20.6% since last year same period to -189% in the Q1 2023. On a quarterly growth basis, BIODESIX INC has generated 10.72% jump in its net profit margins since last 3-months.

BIODESIX INC’s earning per share (EPS) estimates for the current quarter stand at -0.29 - a 12.12% jump from last quarter’s estimates.

BIODESIX INC’s earning per share (EPS) estimates for the current year stand at -0.29.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. BIODESIX INC’s return on assets (ROA) stands at -0.46.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. BIODESIX INC’s return on equity (ROE) stands at -11.12.